---

---

symbols : GILD    crawled time : 20:00   

save search

---

Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320 |

Communications

| -1.12% | O: -100.0% H: NaN% C: Infinity%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -2.0% | O: 0.5% H: 0.83% C: 0.28%
CTXR | $0.7477 -7.18% -7.73% 1.7M |

Health Technology

| -11.79% | O: 2.33% H: 2.28% C: -4.23%
hope treatment pharmaceuticals city for car-t trial

---

Leap Therapeutics Announces $40 Million Private Placement
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
LPTX | $2.81 -5.07% -5.34% 200K |

Health Technology

| -7.89% | O: 15.13% H: 25.43% C: -11.0%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -2.0% | O: 0.5% H: 0.83% C: 0.28%
million leap therapeutics

---

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
Published: 2024-04-02 (Crawled : 20:00) - globenewswire.com
RMD | $178.85 0.7% 0.0% 1.2M |

Health Technology

| -2.99% | O: 0.88% H: 1.64% C: 0.03%
LUNG | $7.52 0.27% 0.27% 350K |

Health Technology

| -11.75% | O: 0.59% H: 1.64% C: -7.13%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -7.39% | O: -0.12% H: 0.24% C: -1.54%
financial

---

Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-04-01 (Crawled : 20:00) - globenewswire.com
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -8.4% | O: -0.08% H: 0.04% C: -1.0%
business year pipeline therapeutics financial results

---

Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
Published: 2024-03-28 (Crawled : 20:00) - globenewswire.com
ASMB | $13.64 2.33% 2.27% 11K |

Health Technology

| Email alert Add to watchlist
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| Email alert Add to watchlist
year financial results

---

Liver Disease Therapeutics Competitive Landscape and Market Forecasts to 2028
Published: 2024-02-12 (Crawled : 20:00) - prnewswire.com
ALPMY | $9.47 -1.11% 520K |

Manufacturing

| -12.2% | O: 0.37% H: 0.74% C: 0.28%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -1.65% | O: -0.18% H: 0.48% C: -1.91%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| -3.85% | O: 0.8% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| 0.22% | O: -0.06% H: 0.0% C: 0.0%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -10.33% | O: 0.32% H: 0.11% C: -1.55%
ALNY | $144.315 -0.58% -0.59% 700K |

Health Technology

| -14.72% | O: -2.63% H: 0.98% C: -1.75%
liver disease therapeutics market

---

Lyndra Therapeutics Announces Positive Data from Pivotal Phase 3 Study with Oral Weekly Risperidone (LYN-005) for Schizophrenia
Published: 2024-01-04 (Crawled : 20:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -20.03% | O: 0.37% H: 1.38% C: 0.82%
lyn-005 positive schizophrenia therapeutics study

---

RedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola
Published: 2023-12-20 (Crawled : 20:00) - biospace.com/
RDHL | $0.4519 7.39% 6.88% 330K |

Health Technology

| -65.91% | O: 9.09% H: 20.83% C: -2.78%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -16.01% | O: 0.21% H: 0.15% C: -1.34%
rhb-107 ebola opaganib show

---

Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies for presentation at ASH 2023
Published: 2023-11-02 (Crawled : 20:00) - globenewswire.com
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -17.81% | O: 0.95% H: 0.72% C: -0.5%
GLPG | News | $29.095 0.64% 0.64% 87K |

Health Technology

| -15.78% | O: 6.34% H: 2.04% C: 0.93%
presentation car-t results

---

Galapagos concludes strategic evaluation and signs letter of intent to transfer Jyseleca® business to Alfasigma
Published: 2023-10-30 (Crawled : 20:00) - globenewswire.com
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -14.16% | O: -0.23% H: 1.44% C: 1.22%
GLPG | News | $29.095 0.64% 0.64% 87K |

Health Technology

| -11.5% | O: -0.27% H: 2.29% C: 2.04%
jyseleca transfer business

---

Lyell Immunopharma Appoints Matthew Lang as Chief Business Officer
Published: 2023-07-05 (Crawled : 20:00) - globenewswire.com
LYEL | $2.24 -3.86% -4.02% 1.1M |

Professional, Scientific, and T...

| -27.6% | O: -2.6% H: 0.0% C: -4.5%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -13.57% | O: -0.43% H: 0.17% C: -0.87%
business

---

Galapagos appoints Thad Huston as Chief Financial Officer and Chief Operating Officer
Published: 2023-06-15 (Crawled : 20:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -9.66% | O: 0.46% H: 0.31% C: -0.15%
LIVN | $52.31 -0.85% -0.86% 430K |

Health Technology

| 8.12% | O: 1.2% H: 1.92% C: 1.59%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -15.49% | O: 0.32% H: 0.35% C: -0.49%
GLPG | News | $29.095 0.64% 0.64% 87K |

Health Technology

| -31.51% | O: 0.35% H: 1.23% C: -0.49%
financial

---

Galapagos demonstrates commitment to immunology with new data in rheumatoid arthritis at EULAR 2023
Published: 2023-05-22 (Crawled : 20:00) - globenewswire.com
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -15.09% | O: -0.03% H: 1.22% C: -0.03%
GLPG | News | $29.095 0.64% 0.64% 87K |

Health Technology

| -34.68% | O: 0.31% H: 1.23% C: -0.45%
immunology

---

Galapagos announces first quarter 2023 financial results
Published: 2023-05-04 (Crawled : 20:00) - globenewswire.com
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -14.98% | O: 0.29% H: 1.37% C: 1.27%
GLPG | News | $29.095 0.64% 0.64% 87K |

Health Technology

| -28.2% | O: 2.86% H: 3.14% C: 2.95%
financial results

---

Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics
Published: 2023-03-06 (Crawled : 20:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50 |

n/a

| -10.86% | O: -0.86% H: 0.33% C: 0.33%
CSLLY | $86.918 3.3% 60K |

n/a

| -12.35% | O: -0.02% H: 0.54% C: -1.7%
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| 4.61% | O: -2.57% H: 1.62% C: 1.62%
TMO | News | $544.78 0.6% 0.0% 1.7M |

Health Technology

| -2.46% | O: 0.41% H: 0.39% C: -2.14%
TEVA | $12.86 0.63% 0.0% 10M |

Health Technology

| 29.77% | O: -1.21% H: 0.43% C: -3.58%
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -15.35% | O: 0.83% H: 0.06% C: -1.2%
PRGO | News | $30.8 2.87% -1.14% 1.2M |

Health Technology

| -16.67% | O: 0.76% H: 1.91% C: 1.26%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 15.38% | O: 0.32% H: 0.17% C: -1.53%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 127.71% | O: 0.01% H: 0.42% C: -2.62%
CTLT | $55.48 -0.57% -0.4% 1.6M |

Health Technology

| -22.23% | O: 0.11% H: 0.53% C: -5.05%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -28.98% | O: 0.41% H: 0.04% C: -1.71%
ALB | $112.15 0.31% -0.13% 2M |

Process Industries

| -56.34% | O: -0.95% H: 1.02% C: -2.19%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 7.17% | O: 0.19% H: 0.06% C: -1.7%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -3.0% | O: 0.65% H: 0.0% C: 0.0%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -17.69% | O: 0.23% H: 0.0% C: -1.25%
BIIB | $194.39 2.03% 1.99% 1.6M |

Health Technology

| -28.07% | O: 0.28% H: 0.0% C: -2.26%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 6.18% | O: 0.9% H: 0.28% C: -1.3%
global report market

---

Global Antiviral Therapeutics Market 2022 to 2027 - Rising Prevalence of Viral Diseases like HIV and Hepatitis Drives Growth
Published: 2023-01-16 (Crawled : 20:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -7.27% | O: -0.2% H: 0.0% C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -45.66% | O: -2.74% H: 0.43% C: -0.99%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -14.71% | O: 0.33% H: 0.33% C: -0.94%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -32.52% | O: 0.83% H: 0.52% C: -1.09%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -5.49% | O: -0.01% H: 0.69% C: -0.1%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -6.05% | O: 1.1% H: 0.22% C: 0.02%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -22.62% | O: -0.26% H: 0.37% C: -0.74%
COCP | $1.495 -1.39% 7.6K |

Health Technology

| -28.5% | O: 0.47% H: 11.16% C: 7.91%
hepatitis global antiviral hiv therapeutics growth market

---

Gilead Foundation Awards $20 Million to Organizations Working to Advance Health Through Education Equity
Published: 2022-09-13 (Crawled : 20:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -1.84% | O: -0.9% H: 0.0% C: -3.41%
awards education health

---

Second Genome Presents New Data at Digestive Disease Week (DDW) 2022 Demonstrating that SG-5-00455, a Potential First-in-Class Precision Therapeutic, Improves Epithelial Barrier Function and Promotes Mucosal Healing in Inflammatory Bowel Disease
Published: 2022-05-24 (Crawled : 20:00) - prnewswire.com
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| 4.59% | O: 0.97% H: 1.15% C: 0.87%
disease week potential

---

Jounce Therapeutics to Announce First Quarter 2022 Financial Results and Host Conference Call on Thursday, May 5, 2022
Published: 2022-04-28 (Crawled : 20:00) - biospace.com/
JNCE | $1.88 -2.59% -1.85% 0 |

Health Technology

| -68.59% | O: 0.66% H: 0.49% C: -6.05%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| 8.39% | O: -0.81% H: 0.0% C: 0.0%
conference therapeutics results

---

Altesa BioSciences Announces Scientific Advisory Board
Published: 2022-02-28 (Crawled : 20:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| 9.69% | O: -1.0% H: 0.37% C: 0.25%
bioscience

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---